Cuproptosis and anti-tumor immunity: bidirectional regulation, controversies, and translational prospects
The cuproptosis-immunity intersection remains at an early stage; key mechanistic findings require independent validation before clinical translation and core controversies regarding the universality of cuproptosis immunogenicity, the immune activation window of copper ions, and the clinical utility of cuproptosis bioma...